iTRAQ-Based Quantitative Proteomics Analysis of HeLa Cells Infected With Chlamydia muridarum TC0668 Mutant and

Yingzi Wang1,2, Emmanuel Wirekoh Arthur1,2, Na Liu1,2

  • 1Institute of Pathogenic Biology, Hengyang Medical College, University of South China, Hengyang, China.

Frontiers in Microbiology
|December 3, 2019
PubMed

Insights

Chlamydia muridarum virulence protein TC0668 drives genital tract pathology by promoting inflammation and fibrosis. Its absence reduces damage, implicating TC0668 in Chlamydia trachomatis pathogenesis.

Area of Science:

  • Microbiology
  • Immunology
  • Proteomics

Background:

  • Chlamydia muridarum establishes a murine model for Chlamydia trachomatis upper genital tract infection.
  • TC0668 is a hypothetical virulence protein in C. muridarum implicated in pathogenesis.
  • Mutant strains lacking TC0668 exhibit reduced pathological damage.

Purpose of the Study:

  • To investigate the role of TC0668 in C. muridarum-induced genital tract pathogenesis.
  • To identify differentially expressed proteins and affected signaling pathways using quantitative proteomics.
  • To validate proteomic findings and analyze protein-protein interactions related to inflammation and fibrosis.

Main Methods:

  • Isobaric tags for relative and absolute quantitation (iTRAQ) for quantitative proteomics.
  • Quantitative real-time PCR (qRT-PCR) for gene expression validation.
  • Western-blotting, immunofluorescence, Gene Ontology (GO), and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses.

Main Results:

  • Proteomics identified 550 differentially expressed proteins at 18 hours post-infection between wild-type and TC0668 mutant strains.
  • qRT-PCR validated the differential expression of key inflammatory and fibrotic proteins.
  • Pathway analysis revealed enrichment in inflammatory responses, fibrosis, and PI3K/Akt and NF-κB signaling pathways.

Conclusions:

  • TC0668 plays a critical role in C. muridarum-induced genital pathology.
  • TC0668 likely induces inflammation and fibrosis via PI3K/Akt and NF-κB signaling.
  • Targeting TC0668 may offer therapeutic strategies for Chlamydia-related diseases.

Related Concept Videos